Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

Abcodia

Website:
abcodia.com
Headquarters:
Boston, MA, US
Company Type:
Small Business (1-10M TTM Revenue)

Abcodia is a clinical stage company engaged in the commercial development of novel, scientifically validated tests for the early detection of cancer. The Company’s first product is the ROCA® Test for the early detection of ovarian cancer. It is also expanding its pipeline of early detection technologies for lung, colorectal and pancreatic cancer.
Our products are based on expertise in measuring and modelling dynamic changes over time of serum-based biomarkers before cancer is clinically diagnosed and it maintains exclusive commercial access to a biobank of prospectively collected samples donated from over 200,000 individuals over a 10-year period.
We hold strategic collaborations with leading global organizations including Cancer Research UK, University College London and other academic and industry partners.
Abcodia is a privately held company funded through investments from Albion Ventures, Cambridge Innovative Capital plc, Scottish Equity Partners and UCL Business Plc. Headquartered in Cambridge, U.K., the Company maintains a U.S. corporate presence in Boston.

Site Badges
Abcodia
3495 Hacks Cross Road Memphis, TN, 38125 United States
Abcodia
Cambourne, England, CB23 6DP United Kingdom
Abcodia
745 Atlantic Avenue Boston, MA, 02111 United States

Get started

If your organization has a Scientist.com marketplace, you can log in here to order products and services directly.

If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here.

To order products instantly, request access below.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service